The Antipsychotic Effects of Omega-3 Fatty Acids in Rats

Background In humans, omega-3 fatty acids are necessary for cell membranes, brain function and nerve transmission continuation. When animals are exposed to a new environment—or as a result of an apomorphine application that creates an agonistic effect on D1 and D2 receptors—they display behavioral r...

Full description

Saved in:
Bibliographic Details
Published in:The American journal of the medical sciences Vol. 350; no. 3; pp. 212 - 217
Main Authors: Kokacya, Mehmet Hanifi, MD, Copoglu, Umit Sertan, MD, Dokuyucu, Recep, MD, Inanir, Sema, MD, Erbas, Oytun, MD
Format: Journal Article
Language:English
Published: United States Elsevier Inc 01-09-2015
Copyright by the Southern Society for Clinical Investigation. Unauthorized reproduction of this article is prohibited
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Background In humans, omega-3 fatty acids are necessary for cell membranes, brain function and nerve transmission continuation. When animals are exposed to a new environment—or as a result of an apomorphine application that creates an agonistic effect on D1 and D2 receptors—they display behavioral reactions like rearing and stereotypy. This study aims to reveal the possible antipsychotic and oxidative effects of omega-3 fatty acids by comparing with chlorpromazine, a conventional antipsychotic drug, through evaluating the novelty-induced rearing and apomorphine-induced stereotypic behaviors, as well as malondialdehyde and glutathione levels in rats. Methods Twenty-eight, adult, male, Wistar rats were used in the study. Briefly, 4 groups of rats (n = 7) were administered docosahexaenoic acid (DHA) + eicosapentaenoic acid (EPA) (300 mg/kg; DHA: 120 mg/kg + EPA: 180 mg/kg intraperitoneally [IP]), DHA + EPA (150 mg/kg; DHA: 60 mg/kg + EPA: 90 mg/kg IP), chlorpromazine (1 mg/kg, IP) and isotonic saline (1 mL/kg, IP). One hour later, apomorphine (2 mg/kg, subcutaneously) was administered to each rat. After the apomorphine administration, rats were observed for stereotypic behavior. Results This study shows that omega-3 fatty acids, “similar to antipsychotics,” reversed the psychotic like effects, increase of oxidants and decrease of antioxidants that are composed experimentally in rats. Conclusions The application of omega-3 fatty acids has antipsychotic effects and causes an oxidative imbalance. This study adds new evidence to the current literature regarding the possible antipsychotic effects of omega-3 fatty acids.
AbstractList BACKGROUND:In humans, omega-3 fatty acids are necessary for cell membranes, brain function and nerve transmission continuation. When animals are exposed to a new environment—or as a result of an apomorphine application that creates an agonistic effect on D1 and D2 receptors—they display behavioral reactions like rearing and stereotypy. This study aims to reveal the possible antipsychotic and oxidative effects of omega-3 fatty acids by comparing with chlorpromazine, a conventional antipsychotic drug, through evaluating the novelty-induced rearing and apomorphine-induced stereotypic behaviors, as well as malondialdehyde and glutathione levels in rats. METHODS:Twenty-eight, adult, male, Wistar rats were used in the study. Briefly, 4 groups of rats (n = 7) were administered docosahexaenoic acid (DHA) + eicosapentaenoic acid (EPA) (300 mg/kg; DHA120 mg/kg + EPA180 mg/kg intraperitoneally [IP]), DHA + EPA (150 mg/kg; DHA60 mg/kg + EPA90 mg/kg IP), chlorpromazine (1 mg/kg, IP) and isotonic saline (1 mL/kg, IP). One hour later, apomorphine (2 mg/kg, subcutaneously) was administered to each rat. After the apomorphine administration, rats were observed for stereotypic behavior. RESULTS:This study shows that omega-3 fatty acids, “similar to antipsychotics,” reversed the psychotic like effects, increase of oxidants and decrease of antioxidants that are composed experimentally in rats. CONCLUSIONS:The application of omega-3 fatty acids has antipsychotic effects and causes an oxidative imbalance. This study adds new evidence to the current literature regarding the possible antipsychotic effects of omega-3 fatty acids.
In humans, omega-3 fatty acids are necessary for cell membranes, brain function and nerve transmission continuation. When animals are exposed to a new environment-or as a result of an apomorphine application that creates an agonistic effect on D1 and D2 receptors-they display behavioral reactions like rearing and stereotypy. This study aims to reveal the possible antipsychotic and oxidative effects of omega-3 fatty acids by comparing with chlorpromazine, a conventional antipsychotic drug, through evaluating the novelty-induced rearing and apomorphine-induced stereotypic behaviors, as well as malondialdehyde and glutathione levels in rats. Twenty-eight, adult, male, Wistar rats were used in the study. Briefly, 4 groups of rats (n = 7) were administered docosahexaenoic acid (DHA) + eicosapentaenoic acid (EPA) (300 mg/kg; DHA: 120 mg/kg + EPA: 180 mg/kg intraperitoneally [IP]), DHA + EPA (150 mg/kg; DHA: 60 mg/kg + EPA: 90 mg/kg IP), chlorpromazine (1 mg/kg, IP) and isotonic saline (1 mL/kg, IP). One hour later, apomorphine (2 mg/kg, subcutaneously) was administered to each rat. After the apomorphine administration, rats were observed for stereotypic behavior. This study shows that omega-3 fatty acids, "similar to antipsychotics," reversed the psychotic like effects, increase of oxidants and decrease of antioxidants that are composed experimentally in rats. The application of omega-3 fatty acids has antipsychotic effects and causes an oxidative imbalance. This study adds new evidence to the current literature regarding the possible antipsychotic effects of omega-3 fatty acids.
BACKGROUNDIn humans, omega-3 fatty acids are necessary for cell membranes, brain function and nerve transmission continuation. When animals are exposed to a new environment-or as a result of an apomorphine application that creates an agonistic effect on D1 and D2 receptors-they display behavioral reactions like rearing and stereotypy. This study aims to reveal the possible antipsychotic and oxidative effects of omega-3 fatty acids by comparing with chlorpromazine, a conventional antipsychotic drug, through evaluating the novelty-induced rearing and apomorphine-induced stereotypic behaviors, as well as malondialdehyde and glutathione levels in rats.METHODSTwenty-eight, adult, male, Wistar rats were used in the study. Briefly, 4 groups of rats (n = 7) were administered docosahexaenoic acid (DHA) + eicosapentaenoic acid (EPA) (300 mg/kg; DHA: 120 mg/kg + EPA: 180 mg/kg intraperitoneally [IP]), DHA + EPA (150 mg/kg; DHA: 60 mg/kg + EPA: 90 mg/kg IP), chlorpromazine (1 mg/kg, IP) and isotonic saline (1 mL/kg, IP). One hour later, apomorphine (2 mg/kg, subcutaneously) was administered to each rat. After the apomorphine administration, rats were observed for stereotypic behavior.RESULTSThis study shows that omega-3 fatty acids, "similar to antipsychotics," reversed the psychotic like effects, increase of oxidants and decrease of antioxidants that are composed experimentally in rats.CONCLUSIONSThe application of omega-3 fatty acids has antipsychotic effects and causes an oxidative imbalance. This study adds new evidence to the current literature regarding the possible antipsychotic effects of omega-3 fatty acids.
In humans, omega-3 fatty acids are necessary for cell membranes, brain function and nerve transmission continuation. When animals are exposed to a new environment—or as a result of an apomorphine application that creates an agonistic effect on D1 and D2 receptors—they display behavioral reactions like rearing and stereotypy. This study aims to reveal the possible antipsychotic and oxidative effects of omega-3 fatty acids by comparing with chlorpromazine, a conventional antipsychotic drug, through evaluating the novelty-induced rearing and apomorphine-induced stereotypic behaviors, as well as malondialdehyde and glutathione levels in rats. Twenty-eight, adult, male, Wistar rats were used in the study. Briefly, 4 groups of rats (n = 7) were administered docosahexaenoic acid (DHA) + eicosapentaenoic acid (EPA) (300mg/kg; DHA: 120mg/kg + EPA: 180mg/kg intraperitoneally [IP]), DHA + EPA (150mg/kg; DHA: 60mg/kg + EPA: 90mg/kg IP), chlorpromazine (1mg/kg, IP) and isotonic saline (1mL/kg, IP). One hour later, apomorphine (2mg/kg, subcutaneously) was administered to each rat. After the apomorphine administration, rats were observed for stereotypic behavior. This study shows that omega-3 fatty acids, “similar to antipsychotics,” reversed the psychotic like effects, increase of oxidants and decrease of antioxidants that are composed experimentally in rats. The application of omega-3 fatty acids has antipsychotic effects and causes an oxidative imbalance. This study adds new evidence to the current literature regarding the possible antipsychotic effects of omega-3 fatty acids.
Background In humans, omega-3 fatty acids are necessary for cell membranes, brain function and nerve transmission continuation. When animals are exposed to a new environment—or as a result of an apomorphine application that creates an agonistic effect on D1 and D2 receptors—they display behavioral reactions like rearing and stereotypy. This study aims to reveal the possible antipsychotic and oxidative effects of omega-3 fatty acids by comparing with chlorpromazine, a conventional antipsychotic drug, through evaluating the novelty-induced rearing and apomorphine-induced stereotypic behaviors, as well as malondialdehyde and glutathione levels in rats. Methods Twenty-eight, adult, male, Wistar rats were used in the study. Briefly, 4 groups of rats (n = 7) were administered docosahexaenoic acid (DHA) + eicosapentaenoic acid (EPA) (300 mg/kg; DHA: 120 mg/kg + EPA: 180 mg/kg intraperitoneally [IP]), DHA + EPA (150 mg/kg; DHA: 60 mg/kg + EPA: 90 mg/kg IP), chlorpromazine (1 mg/kg, IP) and isotonic saline (1 mL/kg, IP). One hour later, apomorphine (2 mg/kg, subcutaneously) was administered to each rat. After the apomorphine administration, rats were observed for stereotypic behavior. Results This study shows that omega-3 fatty acids, “similar to antipsychotics,” reversed the psychotic like effects, increase of oxidants and decrease of antioxidants that are composed experimentally in rats. Conclusions The application of omega-3 fatty acids has antipsychotic effects and causes an oxidative imbalance. This study adds new evidence to the current literature regarding the possible antipsychotic effects of omega-3 fatty acids.
Author Erbas, Oytun
Dokuyucu, Recep
Inanir, Sema
Kokacya, Mehmet Hanifi
Copoglu, Umit Sertan
AuthorAffiliation Departments of Psychiatry (MHK, USC) and Physiology (RD), Faculty of Medicine, Mustafa Kemal University, Hatay, Turkey; and Departments of Psychiatry (SI) and Physiology (OE), Faculty of Medicine, Gaziosmanpasa University, Tokat, Turkey
AuthorAffiliation_xml – name: Departments of Psychiatry (MHK, USC) and Physiology (RD), Faculty of Medicine, Mustafa Kemal University, Hatay, Turkey; and Departments of Psychiatry (SI) and Physiology (OE), Faculty of Medicine, Gaziosmanpasa University, Tokat, Turkey
Author_xml – sequence: 1
  fullname: Kokacya, Mehmet Hanifi, MD
– sequence: 2
  fullname: Copoglu, Umit Sertan, MD
– sequence: 3
  fullname: Dokuyucu, Recep, MD
– sequence: 4
  fullname: Inanir, Sema, MD
– sequence: 5
  fullname: Erbas, Oytun, MD
BackLink https://www.ncbi.nlm.nih.gov/pubmed/26200950$$D View this record in MEDLINE/PubMed
BookMark eNqVkU1LHEEQhpugxNXkHwSZo5fR_pjpj4uwiCaKIhhzbnp6qrOts9Nrd09k_316WRPEi1iXguJ93yqe2kc7YxgBoW8EHxOsxMnN_OoYv66WkU9oRloma6oU3kGzMqS14lTtof2UHjAmVBL2Ge1RTjFWLZ4heb-Aaj5mv0pruwjZ2-rcObA5VcFVt0v4bWpWXZic19Xc-j5VfqzuTE5f0K4zQ4KvL_0A_bo4vz_7UV_ffr88m1_XtuGc1FKBpKoc4oTjHVXMkqYTzIm2F70gjmPDe0GdaKyhzAhMJSOdkh3hIKCz7AAdbXNXMTxNkLJe-mRhGMwIYUqaCCylkq1QRdpspTaGlCI4vYp-aeJaE6w3zHRhpt8yK7bDlw1Tt4T-v-kfpCKQW8FzGDLE9DhMzxD1AsyQF-9ln26tUBD98cWVrIfRQu9jgaz74D8aYAc_emuGR1hDeghTHAt-TXSiGuufm5dvPk7ahlCuJPsLUJ-eyw
CitedBy_id crossref_primary_10_1007_s00238_020_01757_2
crossref_primary_10_1155_2017_6285218
crossref_primary_10_1007_s11695_023_06560_z
crossref_primary_10_1002_ddr_22225
crossref_primary_10_1177_0271678X241261949
Cites_doi 10.1016/S0896-6273(04)00048-0
10.1176/appi.ajp.158.12.2071
10.1080/09540260600581993
10.1016/j.schres.2012.08.014
10.1038/sj.bjp.0702350
10.1016/j.neulet.2010.05.088
10.1016/j.jnutbio.2008.12.015
10.1016/j.lfs.2014.11.025
10.1016/j.biopsych.2013.06.007
10.1016/j.neuroscience.2013.11.049
10.1001/archgenpsychiatry.2009.192
10.1093/brain/122.4.593
10.1016/S0022-3956(01)00048-6
10.1016/j.pnpbp.2013.06.007
10.1016/0014-2999(78)90236-4
10.1001/archgenpsychiatry.2008.514
10.4196/kjpp.2009.13.2.71
10.2174/157015911795596595
10.1080/10715760701324067
10.1016/j.neubiorev.2010.10.008
10.4088/JCP.v68n1206
10.1016/j.pnpbp.2008.07.001
10.1176/ajp.148.11.1474
10.1097/JCP.0b013e318248b7bb
10.1385/MN:32:1:089
10.1016/j.schres.2013.02.001
10.1523/JNEUROSCI.03-08-01607.1983
10.1016/S0920-9964(01)00334-6
10.1146/annurev.neuro.25.112701.142754
10.1126/science.1355616
10.3389/fgene.2013.00208
10.1016/j.jep.2012.06.026
10.1016/S0278-5846(02)00220-8
10.1016/j.plefa.2013.11.002
10.1093/ajcn/64.3.297
10.1016/j.pnpbp.2006.09.012
10.1093/sw/53.1.77
10.1038/sj.mp.4000956
10.1016/0024-3205(84)90519-8
10.1016/0003-9861(59)90090-6
10.1016/j.cbi.2013.10.008
10.1023/A:1006875010120
10.1016/0003-2697(76)90527-3
10.1007/BF02859265
10.1016/S0024-3205(00)00638-X
10.1016/j.jep.2004.10.003
10.1007/s00213-005-0117-1
10.1016/j.plefa.2003.08.015
10.1093/oxfordjournals.schbul.a007038
10.1038/mp.2011.20
10.1111/j.1399-5618.2009.00717.x
10.1016/S0920-9964(00)00083-9
10.1016/S0920-9964(97)00151-5
10.1016/j.schres.2012.08.002
10.1155/2013/686304
10.1016/0920-9964(94)90043-4
ContentType Journal Article
Copyright Southern Society for Clinical Investigation
2015 Southern Society for Clinical Investigation
Copyright © 2015 by the Southern Society for Clinical Investigation. Unauthorized reproduction of this article is prohibited.
Copyright_xml – notice: Southern Society for Clinical Investigation
– notice: 2015 Southern Society for Clinical Investigation
– notice: Copyright © 2015 by the Southern Society for Clinical Investigation. Unauthorized reproduction of this article is prohibited.
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.1097/MAJ.0000000000000531
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList
MEDLINE
MEDLINE - Academic


Database_xml – sequence: 1
  dbid: ECM
  name: MEDLINE
  url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1538-2990
EndPage 217
ExternalDocumentID 10_1097_MAJ_0000000000000531
26200950
10.1097/MAJ.0000000000000531
S0002962915412698
1_s2_0_S0002962915412698
Genre Journal Article
GroupedDBID ---
.-D
.1-
.55
.FO
.GJ
.Z2
0R~
123
1P~
23M
354
41~
457
4Q1
4Q2
4Q3
53G
5RE
5VS
6J9
6TS
71W
7X3
AADOR
AAKAS
AALRI
AAXUO
ABBUW
ABJNI
ABPPZ
ABZAD
ACDDN
ACGFO
ACGFS
ACWDW
ACWRI
ADBIZ
ADFPA
ADMHG
ADOJD
ADZCM
AE3
AENEX
AEVXI
AFCTW
AFETI
AFFNX
AFJKZ
AFRHN
AFTJW
AFTRI
AFUWQ
AGHFR
AGINI
AHPAA
AHRYX
AHVBC
AI.
AITUG
AIZYK
AJUYK
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
AWKKM
BS7
C45
CS3
D1Z
E.X
EBS
EJD
EX3
F2K
F2L
F5P
FDB
FL-
H0~
HYQOX
HZ~
IN~
IS.
JF9
JG8
JK3
JK8
K8S
KD2
KMI
L7B
LPU
M1B
MVM
N4W
N9A
N~M
O9-
OAG
OAH
OBH
OCUKA
ODA
OD~
OHH
OHT
OL1
OLB
OLG
OLV
OLZ
ORVUJ
OVD
OWU
OWV
OWW
OWX
OWY
OWZ
P-K
P2P
R58
ROL
S4R
S4S
T8P
TEORI
UQL
V2I
VH1
VVN
W3M
WH7
WOQ
WOW
X3V
X3W
X7M
XXN
XYM
YOC
YXB
Z5R
ZGI
ZXP
~02
AAIAV
AHPSJ
AQNKT
-
02
08R
0R
1P
41
55
AAPBV
ABFLS
ADKZR
AJYGW
AQIPR
FO
GJ
H0
HZ
IN
M41
OD
RIG
RLZ
RSW
Z2
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c4661-89e829000f7f6b293c14b73f75d7d71f60a6d72f74ca23a702831b98b16e7ebc3
ISSN 0002-9629
IngestDate Fri Oct 25 22:42:34 EDT 2024
Thu Nov 21 21:50:49 EST 2024
Tue Oct 15 23:49:42 EDT 2024
Thu Aug 13 19:54:42 EDT 2020
Fri Feb 23 02:25:18 EST 2024
Tue Oct 15 14:38:10 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords Antipsychotic effect
Oxidative stress
Omega-3 fatty acids
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c4661-89e829000f7f6b293c14b73f75d7d71f60a6d72f74ca23a702831b98b16e7ebc3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 26200950
PQID 1708898579
PQPubID 23479
PageCount 6
ParticipantIDs proquest_miscellaneous_1708898579
crossref_primary_10_1097_MAJ_0000000000000531
pubmed_primary_26200950
wolterskluwer_health_10_1097_MAJ_0000000000000531
elsevier_sciencedirect_doi_10_1097_MAJ_0000000000000531
elsevier_clinicalkeyesjournals_1_s2_0_S0002962915412698
ProviderPackageCode C45
.Z2
ADFPA
AWKKM
OLG
ODA
ABZAD
ABBUW
JK3
OBH
JK8
H0~
ORVUJ
OLV
JG8
X3V
OLZ
X3W
F2K
ACDDN
ACWRI
F2L
AHVBC
FL-
KMI
K8S
V2I
E.X
OWW
OCUKA
OWY
S4R
S4S
4Q1
OAG
4Q2
OL1
4Q3
OAH
IN~
KD2
ACWDW
JF9
OVD
71W
PublicationCentury 2000
PublicationDate 2015-September
PublicationDateYYYYMMDD 2015-09-01
PublicationDate_xml – month: 09
  year: 2015
  text: 2015-September
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle The American journal of the medical sciences
PublicationTitleAlternate Am J Med Sci
PublicationYear 2015
Publisher Elsevier Inc
Copyright by the Southern Society for Clinical Investigation. Unauthorized reproduction of this article is prohibited
Publisher_xml – name: Elsevier Inc
– name: Copyright by the Southern Society for Clinical Investigation. Unauthorized reproduction of this article is prohibited
References Lewis, Levitt (bb0015) 2002; 25
Corcoran, Walker, Huot (bb0020) 2003; 29
Bradford (bb0170) 1976; 72
Creese, Manian, Prosser (bb0220) 1978; 47
Walting (bb0190) 1998
Howes, Montgomery, Asselin (bb0255) 2009; 66
Fusar-Poli, Berger (bb0080) 2012; 32
Erbas, Akseki, Elikucuk (bb0235) 2013; 2013
Harrison (bb0025) 1999; 122
Gama, Canever, Panizzutti (bb0115) 2012; 141
Kunz, Gama, Andreazza (bb0070) 2008; 32
Pearce (bb0030) 2001; 6
Reavill, Kettle, Holland (bb0155) 1999; 126
Peet, Horrobin (bb0085) 2002; 36
Zugno, Chipindo, Canever (bb0270) 2015; 121
Peet, Brind, Ramchand (bb0275) 2001; 49
Horrobin, Glen, Vaddadi (bb0100) 1994; 13
Ballesteros, Jiang, Summerfelt (bb0090) 2013; 146
Amminger, Schäfer, Papageorgiou (bb0200) 2010; 67
Dokuyucu, Kokacya, Inanir (bb0230) 2014; 7
Stadtman (bb0045) 1992; 257
Tappia, Ladha, Clark (bb0205) 1997; 166
Shaaban, Shaker, Zalata (bb0140) 2014; 207
Horrobin (bb0055) 1998; 30
Barnes (bb0180) 2008; 53
Padurariu, Ciobica, Dobrin (bb0060) 2010; 479
Wang, Shao, Sun (bb0065) 2009; 11
Yao, Gainetdinov, Arbuckle (bb0215) 2004; 41
Mahadik, Pillai, Joshi (bb0130) 2006; 18
Sotoing Taïwe, Ngo Bum, Talla (bb0185) 2012; 143
Bitanihirwe, Woo (bb0035) 2011; 35
Howes, Bose, Turkheimer (bb0260) 2011; 16
Boskovic, Vovk, Plesničar (bb0040) 2011; 9
English, Harauma, Föcking (bb0300) 2013; 4
Chiodo, Bunney (bb0225) 1983; 3
Akyol, Herken, Uz (bb0050) 2002; 26
Amos, Abbah, Chindo (bb0160) 2005; 97
Grignon, Chianetta (bb0305) 2007; 31
Davis, Kahn, Ko (bb0010) 1991; 148
Giordano, Visioli (bb0285) 2014; 90
Berger, Proffitt, McConchie (bb0075) 2007; 68
Dong, Kim, Heo (bb0150) 2009; 13
Bazan (bb0240) 2005; 32
Palozza, Sgarlata, Luberto (bb0290) 1996; 64
Fenton, Dickerson, Boronow (bb0280) 2001; 158
Demougeot, Marie, Beley (bb0165) 2000; 67
Bondi, Taha, Tock (bb0265) 2014; 75
Trevizol, Roversi, Dias (bb0125) 2013; 45
Kawashima, Harada, Tami (bb0135) 2010; 21
Yao, Sistilli, van Kammen (bb0250) 2003; 69
Ajayi, Ukponmwan (bb0145) 1994; 23
Ellman (bb0175) 1959; 82
Khan, Evans, Gunna (bb0245) 2002; 58
Dakhale, Khanzode, Khanzode (bb0210) 2005; 182
Avramovic, Dragutinovic, Krstic (bb0110) 2012; 16
Leonardi, Attorri, Benedetto (bb0295) 2007; 41
van der Kemp, Klomp, Kahn (bb0105) 2012; 141
Stoof, Kebabian (bb0195) 1984; 35
Singh (bb0095) 2005; 72
Zugno, Chipindo, Volpato (bb0120) 2013; 259
Wang (10.1097/MAJ.0000000000000531_bb0065) 2009; 11
Corcoran (10.1097/MAJ.0000000000000531_bb0020) 2003; 29
Amminger (10.1097/MAJ.0000000000000531_bb0200) 2010; 67
Grignon (10.1097/MAJ.0000000000000531_bb0305) 2007; 31
Yao (10.1097/MAJ.0000000000000531_bb0250) 2003; 69
Barnes (10.1097/MAJ.0000000000000531_bb0180) 2008; 53
Bondi (10.1097/MAJ.0000000000000531_bb0265) 2014; 75
Horrobin (10.1097/MAJ.0000000000000531_bb0055) 1998; 30
Palozza (10.1097/MAJ.0000000000000531_bb0290) 1996; 64
Erbas (10.1097/MAJ.0000000000000531_bb0235) 2013; 2013
Avramovic (10.1097/MAJ.0000000000000531_bb0110) 2012; 16
Padurariu (10.1097/MAJ.0000000000000531_bb0060) 2010; 479
Kawashima (10.1097/MAJ.0000000000000531_bb0135) 2010; 21
Stadtman (10.1097/MAJ.0000000000000531_bb0045) 1992; 257
Bazan (10.1097/MAJ.0000000000000531_bb0240) 2005; 32
Stoof (10.1097/MAJ.0000000000000531_bb0195) 1984; 35
Boskovic (10.1097/MAJ.0000000000000531_bb0040) 2011; 9
Howes (10.1097/MAJ.0000000000000531_bb0255) 2009; 66
Ajayi (10.1097/MAJ.0000000000000531_bb0145) 1994; 23
Zugno (10.1097/MAJ.0000000000000531_bb0120) 2013; 259
Gama (10.1097/MAJ.0000000000000531_bb0115) 2012; 141
Tappia (10.1097/MAJ.0000000000000531_bb0205) 1997; 166
Reavill (10.1097/MAJ.0000000000000531_bb0155) 1999; 126
Sotoing Taïwe (10.1097/MAJ.0000000000000531_bb0185) 2012; 143
Fusar-Poli (10.1097/MAJ.0000000000000531_bb0080) 2012; 32
Walting (10.1097/MAJ.0000000000000531_bb0190) 1998
Peet (10.1097/MAJ.0000000000000531_bb0085) 2002; 36
Howes (10.1097/MAJ.0000000000000531_bb0260) 2011; 16
Shaaban (10.1097/MAJ.0000000000000531_bb0140) 2014; 207
Peet (10.1097/MAJ.0000000000000531_bb0275) 2001; 49
Chiodo (10.1097/MAJ.0000000000000531_bb0225) 1983; 3
van der Kemp (10.1097/MAJ.0000000000000531_bb0105) 2012; 141
Bradford (10.1097/MAJ.0000000000000531_bb0170) 1976; 72
Giordano (10.1097/MAJ.0000000000000531_bb0285) 2014; 90
English (10.1097/MAJ.0000000000000531_bb0300) 2013; 4
Bitanihirwe (10.1097/MAJ.0000000000000531_bb0035) 2011; 35
Dokuyucu (10.1097/MAJ.0000000000000531_bb0230) 2014; 7
Zugno (10.1097/MAJ.0000000000000531_bb0270) 2015; 121
Creese (10.1097/MAJ.0000000000000531_bb0220) 1978; 47
Horrobin (10.1097/MAJ.0000000000000531_bb0100) 1994; 13
Leonardi (10.1097/MAJ.0000000000000531_bb0295) 2007; 41
Kunz (10.1097/MAJ.0000000000000531_bb0070) 2008; 32
Fenton (10.1097/MAJ.0000000000000531_bb0280) 2001; 158
Yao (10.1097/MAJ.0000000000000531_bb0215) 2004; 41
Amos (10.1097/MAJ.0000000000000531_bb0160) 2005; 97
Davis (10.1097/MAJ.0000000000000531_bb0010) 1991; 148
Akyol (10.1097/MAJ.0000000000000531_bb0050) 2002; 26
Demougeot (10.1097/MAJ.0000000000000531_bb0165) 2000; 67
Harrison (10.1097/MAJ.0000000000000531_bb0025) 1999; 122
Trevizol (10.1097/MAJ.0000000000000531_bb0125) 2013; 45
Singh (10.1097/MAJ.0000000000000531_bb0095) 2005; 72
Ellman (10.1097/MAJ.0000000000000531_bb0175) 1959; 82
Mahadik (10.1097/MAJ.0000000000000531_bb0130) 2006; 18
Ballesteros (10.1097/MAJ.0000000000000531_bb0090) 2013; 146
Pearce (10.1097/MAJ.0000000000000531_bb0030) 2001; 6
Khan (10.1097/MAJ.0000000000000531_bb0245) 2002; 58
Lewis (10.1097/MAJ.0000000000000531_bb0015) 2002; 25
Dakhale (10.1097/MAJ.0000000000000531_bb0210) 2005; 182
Berger (10.1097/MAJ.0000000000000531_bb0075) 2007; 68
Dong (10.1097/MAJ.0000000000000531_bb0150) 2009; 13
References_xml – volume: 122
  start-page: 593
  year: 1999
  end-page: 624
  ident: bb0025
  article-title: The neuropathology of schizophrenia. A critical review of the data and their interpretation
  publication-title: Brain
  contributor:
    fullname: Harrison
– volume: 49
  start-page: 243
  year: 2001
  end-page: 251
  ident: bb0275
  article-title: Two double-blind placebo-controlled pilot studies of eicosapentaenoic acid in the treatment of schizophrenia
  publication-title: Schizophr Res
  contributor:
    fullname: Ramchand
– volume: 32
  start-page: 1677
  year: 2008
  end-page: 1681
  ident: bb0070
  article-title: Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in different phases of bipolar disorder and in schizo-phrenia
  publication-title: Prog Neuropsychopharmacol Biol Psychiatry
  contributor:
    fullname: Andreazza
– volume: 158
  start-page: 2071
  year: 2001
  end-page: 2074
  ident: bb0280
  article-title: A placebo-controlled trial of omega-3 fatty acid (ethyl eicosapentaenoic acid) supplementation for residual symptoms and cog-nitive impairment in schizophrenia
  publication-title: Am J Psychiatry
  contributor:
    fullname: Boronow
– volume: 68
  start-page: 1867
  year: 2007
  end-page: 1875
  ident: bb0075
  article-title: Ethyl-eicosapentaenoic acid in first-episode psycho-sis: a randomized, placebo-controlled trial
  publication-title: J Clin Psychiatry
  contributor:
    fullname: McConchie
– volume: 26
  start-page: 995
  year: 2002
  end-page: 1005
  ident: bb0050
  article-title: The indices of endogenous oxidative and antioxidative processes in plasma from schizophrenic patients: the possible role of oxidant/antioxidant imbalance
  publication-title: Prog Neuropsychopharmacol Biol Psychiatry
  contributor:
    fullname: Uz
– volume: 35
  start-page: 2281
  year: 1984
  end-page: 2296
  ident: bb0195
  article-title: Two dopamine receptors: biochemistry, physiology and pharmacology
  publication-title: Life Sci
  contributor:
    fullname: Kebabian
– volume: 259
  start-page: 223
  year: 2013
  end-page: 231
  ident: bb0120
  article-title: Omega-3 prevents behavior response and brain oxidative damage in the ketamine model of schizophrenia
  publication-title: Neuroscience
  contributor:
    fullname: Volpato
– volume: 166
  start-page: 135
  year: 1997
  end-page: 143
  ident: bb0205
  article-title: The influence of membrane fluidity, TNF receptor binding, cAMP production and GTPase activity on macrophage cyto-kine production in rats fed a variety of fat diets
  publication-title: Mol Cell Biochem
  contributor:
    fullname: Clark
– volume: 207
  start-page: 81
  year: 2014
  end-page: 91
  ident: bb0140
  article-title: Modulation of carbon tetrachloride-induced hepatic oxidative stress, injury and fibrosis by olmesartan and omega-3
  publication-title: Chem Biol Interact
  contributor:
    fullname: Zalata
– volume: 29
  start-page: 671
  year: 2003
  end-page: 692
  ident: bb0020
  article-title: The stress cascade and schizophrenia: etiology and onset
  publication-title: Schizophr Bull
  contributor:
    fullname: Huot
– volume: 9
  start-page: 301
  year: 2011
  ident: bb0040
  article-title: Oxidative stress in schizophrenia
  publication-title: Curr Neuropharmacol
  contributor:
    fullname: Plesničar
– volume: 18
  start-page: 119
  year: 2006
  end-page: 131
  ident: bb0130
  article-title: Prevention of oxidative stress-mediated neuropa-thology and improved clinical outcome by adjunctive use of a combina-tion of antioxidants and omega-3 fatty acids in schizophrenia
  publication-title: Int Rev Psychiatry
  contributor:
    fullname: Joshi
– volume: 90
  start-page: 1
  year: 2014
  end-page: 4
  ident: bb0285
  article-title: Long-chain omega 3 fatty acids: molecular bases of potential antioxidant actions
  publication-title: Prostaglandins Leukot Essent Fatty Acids
  contributor:
    fullname: Visioli
– volume: 58
  start-page: 1
  year: 2002
  end-page: 10
  ident: bb0245
  article-title: Reduced erythrocyte membrane essential fatty acids and increased lipid peroxides in schizophrenia at the never-medicated first-episode of psychosis and after years of treatment with antipsy-chotics
  publication-title: Schizophr Res
  contributor:
    fullname: Gunna
– volume: 32
  start-page: 89
  year: 2005
  end-page: 103
  ident: bb0240
  article-title: Lipid signaling in neural plasticity, brain repair, and neuroprotection
  publication-title: Mol Neurobiol
  contributor:
    fullname: Bazan
– volume: 121
  start-page: 65
  year: 2015
  end-page: 69
  ident: bb0270
  article-title: Omega-3 fatty acids prevent the ketamine-induced increase in acetylcholinesterase activity in an animal model of schizo-phrenia
  publication-title: Life Sci
  contributor:
    fullname: Canever
– volume: 182
  start-page: 494
  year: 2005
  end-page: 498
  ident: bb0210
  article-title: Supplementation of vitamin C with atypical antipsychotics reduces oxidative stress and improves the outcome of schizophrenia
  publication-title: Psychopharmacology
  contributor:
    fullname: Khanzode
– volume: 143
  start-page: 213
  year: 2012
  end-page: 220
  ident: bb0185
  article-title: Antipsychotic and sedative effects of the leaf extract of Crassocephalum bauchiense(Hutch.) Milne-Redh (Astera-ceae) in rodents
  publication-title: J Ethnopharmacol
  contributor:
    fullname: Talla
– volume: 64
  start-page: 297
  year: 1996
  end-page: 304
  ident: bb0290
  article-title: n-3 fatty acids induce oxidative modifications in human erythrocytes depending on dose and duration of dietary supple-mentation
  publication-title: Am J Clin Nutr
  contributor:
    fullname: Luberto
– volume: 75
  start-page: 38
  year: 2014
  end-page: 46
  ident: bb0265
  article-title: Adolescent behavior and dopamine availability are uniquely sensitive to dietary omega-3 fatty acid deficiency
  publication-title: Biol Psy-chiatry
  contributor:
    fullname: Tock
– volume: 16
  start-page: 241
  year: 2012
  ident: bb0110
  article-title: The effects of omega 3 fatty acid supplementa-tion on brain tissue oxidative status in aged wistar rats
  publication-title: Hippokratia
  contributor:
    fullname: Krstic
– volume: 69
  start-page: 429
  year: 2003
  end-page: 436
  ident: bb0250
  article-title: Membrane polyunsaturated fatty acids and CSF cytokines in patients with schizophrenia
  publication-title: Prostaglandins Leukot Essent Fatty Acids
  contributor:
    fullname: van Kammen
– volume: 30
  start-page: 193
  year: 1998
  end-page: 208
  ident: bb0055
  article-title: The membrane phospholipid hypothesis as a biochemical basis for the neurodevelopmental concept of schizophrenia
  publication-title: Schizophr Res
  contributor:
    fullname: Horrobin
– volume: 31
  start-page: 365
  year: 2007
  end-page: 369
  ident: bb0305
  article-title: Assessment of malondialdehyde levels in schizophrenia: a meta-analysis and some methodological considerations
  publication-title: Prog Neuropsychopharmacol Biol Psychiatry
  contributor:
    fullname: Chianetta
– volume: 25
  start-page: 409
  year: 2002
  end-page: 432
  ident: bb0015
  article-title: Schizophrenia as a disorder of neurodevelopment
  publication-title: Annu Rev Neurosci
  contributor:
    fullname: Levitt
– volume: 82
  start-page: 70
  year: 1959
  end-page: 77
  ident: bb0175
  article-title: Tissue sulfhydryl groups
  publication-title: Arch Biochem Biophys
  contributor:
    fullname: Ellman
– volume: 66
  start-page: 13
  year: 2009
  end-page: 20
  ident: bb0255
  article-title: Elevated striatal dopamine function linked to pro-dromal signs of schizophrenia
  publication-title: Arch Gen Psychiatry
  contributor:
    fullname: Asselin
– volume: 41
  start-page: 748
  year: 2007
  end-page: 756
  ident: bb0295
  article-title: Docosahexaenoic acid supplementation induces dose and time dependent oxidative changes in C6 glioma cells
  publication-title: Free Radic Res
  contributor:
    fullname: Benedetto
– volume: 257
  start-page: 1220
  year: 1992
  end-page: 1224
  ident: bb0045
  article-title: Protein oxidation and aging
  publication-title: Science
  contributor:
    fullname: Stadtman
– volume: 141
  start-page: 153
  year: 2012
  end-page: 161
  ident: bb0105
  article-title: A meta-analysis of the polyunsaturated fatty acid composition of erythrocyte membranes in schizophrenia
  publication-title: Schizophr Res
  contributor:
    fullname: Kahn
– volume: 11
  start-page: 523
  year: 2009
  end-page: 529
  ident: bb0065
  article-title: Increased oxidative stress in the anterior cingulate cortex of subjects with bipolar disorder and schizophrenia
  publication-title: Bipolar Disord
  contributor:
    fullname: Sun
– volume: 35
  start-page: 878
  year: 2011
  end-page: 893
  ident: bb0035
  article-title: Oxidative stress in schizophrenia: an integrated approach
  publication-title: Neurosci Biobehav Rev
  contributor:
    fullname: Woo
– volume: 126
  start-page: 572
  year: 1999
  end-page: 574
  ident: bb0155
  article-title: Attenuation of haloperidol-induced catalepsy by a 5-HT2C receptor antagonist
  publication-title: Br J Pharmacol
  contributor:
    fullname: Holland
– volume: 67
  start-page: 399
  year: 2000
  end-page: 410
  ident: bb0165
  article-title: Importance of iron location in iron-induced hydroxyl radical production by brain slices
  publication-title: Life Sci
  contributor:
    fullname: Beley
– volume: 3
  start-page: 1607
  year: 1983
  end-page: 1619
  ident: bb0225
  article-title: Typical and atypical neuroleptics: differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons
  publication-title: J Neurosci
  contributor:
    fullname: Bunney
– volume: 13
  start-page: 71
  year: 2009
  end-page: 78
  ident: bb0150
  article-title: YKP1447, a novel potential atypical antipsychotic agent
  publication-title: Korean J Physiol Pharmacol
  contributor:
    fullname: Heo
– volume: 141
  start-page: 162
  year: 2012
  end-page: 167
  ident: bb0115
  article-title: Effects of omega-3 dietary supplement in prevention of positive, negative and cognitive symptoms: a study in adolescent rats with ketamine-induced model of schizophrenia
  publication-title: Schizophr Res
  contributor:
    fullname: Panizzutti
– volume: 7
  start-page: 3354
  year: 2014
  end-page: 3361
  ident: bb0230
  article-title: Antipsychotic-like effect of minocycline in a rat model
  publication-title: Int J Clin Exp Med
  contributor:
    fullname: Inanir
– volume: 41
  start-page: 625
  year: 2004
  end-page: 638
  ident: bb0215
  article-title: Identification of PSD-95 as a regulator of dopamine-mediated synaptic and behavioral plasticity
  publication-title: Neuron
  contributor:
    fullname: Arbuckle
– volume: 148
  start-page: 1474
  year: 1991
  end-page: 1486
  ident: bb0010
  article-title: Dopamine in schizophrenia: a review and reconceptualization
  publication-title: Am J Psychiatry
  contributor:
    fullname: Ko
– volume: 16
  start-page: 885
  year: 2011
  end-page: 886
  ident: bb0260
  article-title: Progressive increase in striatal dopamine synthesis capacity as patients develop psychosis: a PET study
  publication-title: Mol Psychiatry
  contributor:
    fullname: Turkheimer
– volume: 2013
  start-page: 686304
  year: 2013
  ident: bb0235
  article-title: Antipsychotic-like effect of trimetazidine in a rodent model
  publication-title: ScientificWorldJournal
  contributor:
    fullname: Elikucuk
– volume: 13
  start-page: 195
  year: 1994
  end-page: 207
  ident: bb0100
  article-title: The membrane hypothesis of schizophrenia
  publication-title: Schizophr Res
  contributor:
    fullname: Vaddadi
– volume: 72
  start-page: 248
  year: 1976
  end-page: 254
  ident: bb0170
  article-title: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
  publication-title: Anal Biochem
  contributor:
    fullname: Bradford
– volume: 72
  start-page: 239
  year: 2005
  end-page: 242
  ident: bb0095
  article-title: Essential fatty acids, DHA and human brain
  publication-title: Indian J Pediatr
  contributor:
    fullname: Singh
– volume: 479
  start-page: 317
  year: 2010
  end-page: 320
  ident: bb0060
  article-title: Evaluation of antioxidant enzymes activities and lipid peroxidation in schizophrenic patients treated with typical and atypical antipsychotics
  publication-title: Neurosci Lett
  contributor:
    fullname: Dobrin
– volume: 97
  start-page: 53
  year: 2005
  end-page: 57
  ident: bb0160
  article-title: Neuropharmacological effects of the aqueous extract of Nauclea latifolia root bark in rats and mice
  publication-title: J Ethnopharmacol
  contributor:
    fullname: Chindo
– volume: 21
  start-page: 268
  year: 2010
  end-page: 277
  ident: bb0135
  article-title: Effects of eicosapentaenoic acid on synaptic plasticity, fatty acid profile and phosphoinositide 3-kinase signaling in rat hippocampus and differentiated PC12 cells
  publication-title: J Nutr Biochem
  contributor:
    fullname: Tami
– volume: 36
  start-page: 7
  year: 2002
  end-page: 18
  ident: bb0085
  article-title: A dose-ranging exploratory study of the effects of ethyl-eicosapentaenoate in patients with persistent schizophrenic symptoms
  publication-title: J Psychiatr Res
  contributor:
    fullname: Horrobin
– start-page: 2
  year: 1998
  end-page: 45
  ident: bb0190
  article-title: Overview of central nervous system receptors
  publication-title: The RBI hand-book of receptor clarification and signal transduction
  contributor:
    fullname: Walting
– volume: 47
  start-page: 291
  year: 1978
  end-page: 296
  ident: bb0220
  article-title: 3H-Haloperidol binding to dopamine receptors in rat corpus striatum: influence of chlorpromazine metabolites and deriva-tives
  publication-title: Eur J Pharmacol
  contributor:
    fullname: Prosser
– volume: 45
  start-page: 215
  year: 2013
  end-page: 222
  ident: bb0125
  article-title: Influence of lifelong dietary fats on the brain fatty acids and amphetamine-induced behavioral responses in adult rat
  publication-title: Prog Neuropsychopharmacol Biol Psychiatry
  contributor:
    fullname: Dias
– volume: 146
  start-page: 184
  year: 2013
  end-page: 189
  ident: bb0090
  article-title: No evidence of exogenous origin for the abnor-mal glutathione redox state in schizophrenia
  publication-title: Schizophr Res
  contributor:
    fullname: Summerfelt
– volume: 53
  start-page: 77
  year: 2008
  end-page: 83
  ident: bb0180
  article-title: Race and hospital diagnoses of schizophrenia and mood disorders
  publication-title: Soc Work
  contributor:
    fullname: Barnes
– volume: 23
  start-page: 287
  year: 1994
  end-page: 290
  ident: bb0145
  article-title: Possible evidence of angiotensin II and endogenous opioid modulation of novelty-induced rearing in the rat
  publication-title: Afr J Med Med Sci
  contributor:
    fullname: Ukponmwan
– volume: 67
  start-page: 146
  year: 2010
  end-page: 154
  ident: bb0200
  article-title: Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial
  publication-title: Arch Gen Psychiatry
  contributor:
    fullname: Papageorgiou
– volume: 4
  start-page: 208
  year: 2013
  ident: bb0300
  article-title: Omega-3 fatty acid deficiency disrupts endocytosis, neuritogenesis, and mitochondrial protein pathways in the mouse hip-pocampus
  publication-title: Front Genet
  contributor:
    fullname: Föcking
– volume: 6
  start-page: 634
  year: 2001
  end-page: 646
  ident: bb0030
  article-title: Schizophrenia and viral infection during neurodevelopment: a focus on mechanisms
  publication-title: Mol Psychiatry
  contributor:
    fullname: Pearce
– volume: 32
  start-page: 179
  year: 2012
  end-page: 185
  ident: bb0080
  article-title: Eicosapentaenoic acid interventions in schizophrenia: meta-analysis of randomized, placebo-controlled studies
  publication-title: J Clin Psychopharmacol
  contributor:
    fullname: Berger
– volume: 41
  start-page: 625
  year: 2004
  ident: 10.1097/MAJ.0000000000000531_bb0215
  article-title: Identification of PSD-95 as a regulator of dopamine-mediated synaptic and behavioral plasticity
  publication-title: Neuron
  doi: 10.1016/S0896-6273(04)00048-0
  contributor:
    fullname: Yao
– volume: 158
  start-page: 2071
  year: 2001
  ident: 10.1097/MAJ.0000000000000531_bb0280
  article-title: A placebo-controlled trial of omega-3 fatty acid (ethyl eicosapentaenoic acid) supplementation for residual symptoms and cog-nitive impairment in schizophrenia
  publication-title: Am J Psychiatry
  doi: 10.1176/appi.ajp.158.12.2071
  contributor:
    fullname: Fenton
– volume: 18
  start-page: 119
  year: 2006
  ident: 10.1097/MAJ.0000000000000531_bb0130
  article-title: Prevention of oxidative stress-mediated neuropa-thology and improved clinical outcome by adjunctive use of a combina-tion of antioxidants and omega-3 fatty acids in schizophrenia
  publication-title: Int Rev Psychiatry
  doi: 10.1080/09540260600581993
  contributor:
    fullname: Mahadik
– volume: 141
  start-page: 153
  year: 2012
  ident: 10.1097/MAJ.0000000000000531_bb0105
  article-title: A meta-analysis of the polyunsaturated fatty acid composition of erythrocyte membranes in schizophrenia
  publication-title: Schizophr Res
  doi: 10.1016/j.schres.2012.08.014
  contributor:
    fullname: van der Kemp
– volume: 23
  start-page: 287
  year: 1994
  ident: 10.1097/MAJ.0000000000000531_bb0145
  article-title: Possible evidence of angiotensin II and endogenous opioid modulation of novelty-induced rearing in the rat
  publication-title: Afr J Med Med Sci
  contributor:
    fullname: Ajayi
– volume: 126
  start-page: 572
  year: 1999
  ident: 10.1097/MAJ.0000000000000531_bb0155
  article-title: Attenuation of haloperidol-induced catalepsy by a 5-HT2C receptor antagonist
  publication-title: Br J Pharmacol
  doi: 10.1038/sj.bjp.0702350
  contributor:
    fullname: Reavill
– volume: 479
  start-page: 317
  year: 2010
  ident: 10.1097/MAJ.0000000000000531_bb0060
  article-title: Evaluation of antioxidant enzymes activities and lipid peroxidation in schizophrenic patients treated with typical and atypical antipsychotics
  publication-title: Neurosci Lett
  doi: 10.1016/j.neulet.2010.05.088
  contributor:
    fullname: Padurariu
– volume: 21
  start-page: 268
  year: 2010
  ident: 10.1097/MAJ.0000000000000531_bb0135
  article-title: Effects of eicosapentaenoic acid on synaptic plasticity, fatty acid profile and phosphoinositide 3-kinase signaling in rat hippocampus and differentiated PC12 cells
  publication-title: J Nutr Biochem
  doi: 10.1016/j.jnutbio.2008.12.015
  contributor:
    fullname: Kawashima
– volume: 121
  start-page: 65
  year: 2015
  ident: 10.1097/MAJ.0000000000000531_bb0270
  article-title: Omega-3 fatty acids prevent the ketamine-induced increase in acetylcholinesterase activity in an animal model of schizo-phrenia
  publication-title: Life Sci
  doi: 10.1016/j.lfs.2014.11.025
  contributor:
    fullname: Zugno
– start-page: 2
  year: 1998
  ident: 10.1097/MAJ.0000000000000531_bb0190
  article-title: Overview of central nervous system receptors
  contributor:
    fullname: Walting
– volume: 75
  start-page: 38
  year: 2014
  ident: 10.1097/MAJ.0000000000000531_bb0265
  article-title: Adolescent behavior and dopamine availability are uniquely sensitive to dietary omega-3 fatty acid deficiency
  publication-title: Biol Psy-chiatry
  doi: 10.1016/j.biopsych.2013.06.007
  contributor:
    fullname: Bondi
– volume: 259
  start-page: 223
  year: 2013
  ident: 10.1097/MAJ.0000000000000531_bb0120
  article-title: Omega-3 prevents behavior response and brain oxidative damage in the ketamine model of schizophrenia
  publication-title: Neuroscience
  doi: 10.1016/j.neuroscience.2013.11.049
  contributor:
    fullname: Zugno
– volume: 67
  start-page: 146
  year: 2010
  ident: 10.1097/MAJ.0000000000000531_bb0200
  article-title: Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial
  publication-title: Arch Gen Psychiatry
  doi: 10.1001/archgenpsychiatry.2009.192
  contributor:
    fullname: Amminger
– volume: 122
  start-page: 593
  year: 1999
  ident: 10.1097/MAJ.0000000000000531_bb0025
  article-title: The neuropathology of schizophrenia. A critical review of the data and their interpretation
  publication-title: Brain
  doi: 10.1093/brain/122.4.593
  contributor:
    fullname: Harrison
– volume: 36
  start-page: 7
  year: 2002
  ident: 10.1097/MAJ.0000000000000531_bb0085
  article-title: A dose-ranging exploratory study of the effects of ethyl-eicosapentaenoate in patients with persistent schizophrenic symptoms
  publication-title: J Psychiatr Res
  doi: 10.1016/S0022-3956(01)00048-6
  contributor:
    fullname: Peet
– volume: 45
  start-page: 215
  year: 2013
  ident: 10.1097/MAJ.0000000000000531_bb0125
  article-title: Influence of lifelong dietary fats on the brain fatty acids and amphetamine-induced behavioral responses in adult rat
  publication-title: Prog Neuropsychopharmacol Biol Psychiatry
  doi: 10.1016/j.pnpbp.2013.06.007
  contributor:
    fullname: Trevizol
– volume: 47
  start-page: 291
  year: 1978
  ident: 10.1097/MAJ.0000000000000531_bb0220
  article-title: 3H-Haloperidol binding to dopamine receptors in rat corpus striatum: influence of chlorpromazine metabolites and deriva-tives
  publication-title: Eur J Pharmacol
  doi: 10.1016/0014-2999(78)90236-4
  contributor:
    fullname: Creese
– volume: 66
  start-page: 13
  year: 2009
  ident: 10.1097/MAJ.0000000000000531_bb0255
  article-title: Elevated striatal dopamine function linked to pro-dromal signs of schizophrenia
  publication-title: Arch Gen Psychiatry
  doi: 10.1001/archgenpsychiatry.2008.514
  contributor:
    fullname: Howes
– volume: 13
  start-page: 71
  year: 2009
  ident: 10.1097/MAJ.0000000000000531_bb0150
  article-title: YKP1447, a novel potential atypical antipsychotic agent
  publication-title: Korean J Physiol Pharmacol
  doi: 10.4196/kjpp.2009.13.2.71
  contributor:
    fullname: Dong
– volume: 9
  start-page: 301
  year: 2011
  ident: 10.1097/MAJ.0000000000000531_bb0040
  article-title: Oxidative stress in schizophrenia
  publication-title: Curr Neuropharmacol
  doi: 10.2174/157015911795596595
  contributor:
    fullname: Boskovic
– volume: 41
  start-page: 748
  year: 2007
  ident: 10.1097/MAJ.0000000000000531_bb0295
  article-title: Docosahexaenoic acid supplementation induces dose and time dependent oxidative changes in C6 glioma cells
  publication-title: Free Radic Res
  doi: 10.1080/10715760701324067
  contributor:
    fullname: Leonardi
– volume: 35
  start-page: 878
  year: 2011
  ident: 10.1097/MAJ.0000000000000531_bb0035
  article-title: Oxidative stress in schizophrenia: an integrated approach
  publication-title: Neurosci Biobehav Rev
  doi: 10.1016/j.neubiorev.2010.10.008
  contributor:
    fullname: Bitanihirwe
– volume: 68
  start-page: 1867
  year: 2007
  ident: 10.1097/MAJ.0000000000000531_bb0075
  article-title: Ethyl-eicosapentaenoic acid in first-episode psycho-sis: a randomized, placebo-controlled trial
  publication-title: J Clin Psychiatry
  doi: 10.4088/JCP.v68n1206
  contributor:
    fullname: Berger
– volume: 32
  start-page: 1677
  year: 2008
  ident: 10.1097/MAJ.0000000000000531_bb0070
  article-title: Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in different phases of bipolar disorder and in schizo-phrenia
  publication-title: Prog Neuropsychopharmacol Biol Psychiatry
  doi: 10.1016/j.pnpbp.2008.07.001
  contributor:
    fullname: Kunz
– volume: 148
  start-page: 1474
  year: 1991
  ident: 10.1097/MAJ.0000000000000531_bb0010
  article-title: Dopamine in schizophrenia: a review and reconceptualization
  publication-title: Am J Psychiatry
  doi: 10.1176/ajp.148.11.1474
  contributor:
    fullname: Davis
– volume: 32
  start-page: 179
  year: 2012
  ident: 10.1097/MAJ.0000000000000531_bb0080
  article-title: Eicosapentaenoic acid interventions in schizophrenia: meta-analysis of randomized, placebo-controlled studies
  publication-title: J Clin Psychopharmacol
  doi: 10.1097/JCP.0b013e318248b7bb
  contributor:
    fullname: Fusar-Poli
– volume: 32
  start-page: 89
  year: 2005
  ident: 10.1097/MAJ.0000000000000531_bb0240
  article-title: Lipid signaling in neural plasticity, brain repair, and neuroprotection
  publication-title: Mol Neurobiol
  doi: 10.1385/MN:32:1:089
  contributor:
    fullname: Bazan
– volume: 146
  start-page: 184
  year: 2013
  ident: 10.1097/MAJ.0000000000000531_bb0090
  article-title: No evidence of exogenous origin for the abnor-mal glutathione redox state in schizophrenia
  publication-title: Schizophr Res
  doi: 10.1016/j.schres.2013.02.001
  contributor:
    fullname: Ballesteros
– volume: 3
  start-page: 1607
  year: 1983
  ident: 10.1097/MAJ.0000000000000531_bb0225
  article-title: Typical and atypical neuroleptics: differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.03-08-01607.1983
  contributor:
    fullname: Chiodo
– volume: 58
  start-page: 1
  year: 2002
  ident: 10.1097/MAJ.0000000000000531_bb0245
  article-title: Reduced erythrocyte membrane essential fatty acids and increased lipid peroxides in schizophrenia at the never-medicated first-episode of psychosis and after years of treatment with antipsy-chotics
  publication-title: Schizophr Res
  doi: 10.1016/S0920-9964(01)00334-6
  contributor:
    fullname: Khan
– volume: 25
  start-page: 409
  year: 2002
  ident: 10.1097/MAJ.0000000000000531_bb0015
  article-title: Schizophrenia as a disorder of neurodevelopment
  publication-title: Annu Rev Neurosci
  doi: 10.1146/annurev.neuro.25.112701.142754
  contributor:
    fullname: Lewis
– volume: 257
  start-page: 1220
  year: 1992
  ident: 10.1097/MAJ.0000000000000531_bb0045
  article-title: Protein oxidation and aging
  publication-title: Science
  doi: 10.1126/science.1355616
  contributor:
    fullname: Stadtman
– volume: 4
  start-page: 208
  year: 2013
  ident: 10.1097/MAJ.0000000000000531_bb0300
  article-title: Omega-3 fatty acid deficiency disrupts endocytosis, neuritogenesis, and mitochondrial protein pathways in the mouse hip-pocampus
  publication-title: Front Genet
  doi: 10.3389/fgene.2013.00208
  contributor:
    fullname: English
– volume: 143
  start-page: 213
  year: 2012
  ident: 10.1097/MAJ.0000000000000531_bb0185
  article-title: Antipsychotic and sedative effects of the leaf extract of Crassocephalum bauchiense(Hutch.) Milne-Redh (Astera-ceae) in rodents
  publication-title: J Ethnopharmacol
  doi: 10.1016/j.jep.2012.06.026
  contributor:
    fullname: Sotoing Taïwe
– volume: 26
  start-page: 995
  year: 2002
  ident: 10.1097/MAJ.0000000000000531_bb0050
  article-title: The indices of endogenous oxidative and antioxidative processes in plasma from schizophrenic patients: the possible role of oxidant/antioxidant imbalance
  publication-title: Prog Neuropsychopharmacol Biol Psychiatry
  doi: 10.1016/S0278-5846(02)00220-8
  contributor:
    fullname: Akyol
– volume: 90
  start-page: 1
  year: 2014
  ident: 10.1097/MAJ.0000000000000531_bb0285
  article-title: Long-chain omega 3 fatty acids: molecular bases of potential antioxidant actions
  publication-title: Prostaglandins Leukot Essent Fatty Acids
  doi: 10.1016/j.plefa.2013.11.002
  contributor:
    fullname: Giordano
– volume: 64
  start-page: 297
  year: 1996
  ident: 10.1097/MAJ.0000000000000531_bb0290
  article-title: n-3 fatty acids induce oxidative modifications in human erythrocytes depending on dose and duration of dietary supple-mentation
  publication-title: Am J Clin Nutr
  doi: 10.1093/ajcn/64.3.297
  contributor:
    fullname: Palozza
– volume: 31
  start-page: 365
  year: 2007
  ident: 10.1097/MAJ.0000000000000531_bb0305
  article-title: Assessment of malondialdehyde levels in schizophrenia: a meta-analysis and some methodological considerations
  publication-title: Prog Neuropsychopharmacol Biol Psychiatry
  doi: 10.1016/j.pnpbp.2006.09.012
  contributor:
    fullname: Grignon
– volume: 7
  start-page: 3354
  year: 2014
  ident: 10.1097/MAJ.0000000000000531_bb0230
  article-title: Antipsychotic-like effect of minocycline in a rat model
  publication-title: Int J Clin Exp Med
  contributor:
    fullname: Dokuyucu
– volume: 53
  start-page: 77
  year: 2008
  ident: 10.1097/MAJ.0000000000000531_bb0180
  article-title: Race and hospital diagnoses of schizophrenia and mood disorders
  publication-title: Soc Work
  doi: 10.1093/sw/53.1.77
  contributor:
    fullname: Barnes
– volume: 6
  start-page: 634
  year: 2001
  ident: 10.1097/MAJ.0000000000000531_bb0030
  article-title: Schizophrenia and viral infection during neurodevelopment: a focus on mechanisms
  publication-title: Mol Psychiatry
  doi: 10.1038/sj.mp.4000956
  contributor:
    fullname: Pearce
– volume: 35
  start-page: 2281
  year: 1984
  ident: 10.1097/MAJ.0000000000000531_bb0195
  article-title: Two dopamine receptors: biochemistry, physiology and pharmacology
  publication-title: Life Sci
  doi: 10.1016/0024-3205(84)90519-8
  contributor:
    fullname: Stoof
– volume: 82
  start-page: 70
  year: 1959
  ident: 10.1097/MAJ.0000000000000531_bb0175
  article-title: Tissue sulfhydryl groups
  publication-title: Arch Biochem Biophys
  doi: 10.1016/0003-9861(59)90090-6
  contributor:
    fullname: Ellman
– volume: 207
  start-page: 81
  year: 2014
  ident: 10.1097/MAJ.0000000000000531_bb0140
  article-title: Modulation of carbon tetrachloride-induced hepatic oxidative stress, injury and fibrosis by olmesartan and omega-3
  publication-title: Chem Biol Interact
  doi: 10.1016/j.cbi.2013.10.008
  contributor:
    fullname: Shaaban
– volume: 166
  start-page: 135
  year: 1997
  ident: 10.1097/MAJ.0000000000000531_bb0205
  article-title: The influence of membrane fluidity, TNF receptor binding, cAMP production and GTPase activity on macrophage cyto-kine production in rats fed a variety of fat diets
  publication-title: Mol Cell Biochem
  doi: 10.1023/A:1006875010120
  contributor:
    fullname: Tappia
– volume: 72
  start-page: 248
  year: 1976
  ident: 10.1097/MAJ.0000000000000531_bb0170
  article-title: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
  publication-title: Anal Biochem
  doi: 10.1016/0003-2697(76)90527-3
  contributor:
    fullname: Bradford
– volume: 72
  start-page: 239
  year: 2005
  ident: 10.1097/MAJ.0000000000000531_bb0095
  article-title: Essential fatty acids, DHA and human brain
  publication-title: Indian J Pediatr
  doi: 10.1007/BF02859265
  contributor:
    fullname: Singh
– volume: 67
  start-page: 399
  year: 2000
  ident: 10.1097/MAJ.0000000000000531_bb0165
  article-title: Importance of iron location in iron-induced hydroxyl radical production by brain slices
  publication-title: Life Sci
  doi: 10.1016/S0024-3205(00)00638-X
  contributor:
    fullname: Demougeot
– volume: 97
  start-page: 53
  year: 2005
  ident: 10.1097/MAJ.0000000000000531_bb0160
  article-title: Neuropharmacological effects of the aqueous extract of Nauclea latifolia root bark in rats and mice
  publication-title: J Ethnopharmacol
  doi: 10.1016/j.jep.2004.10.003
  contributor:
    fullname: Amos
– volume: 16
  start-page: 241
  year: 2012
  ident: 10.1097/MAJ.0000000000000531_bb0110
  article-title: The effects of omega 3 fatty acid supplementa-tion on brain tissue oxidative status in aged wistar rats
  publication-title: Hippokratia
  contributor:
    fullname: Avramovic
– volume: 182
  start-page: 494
  year: 2005
  ident: 10.1097/MAJ.0000000000000531_bb0210
  article-title: Supplementation of vitamin C with atypical antipsychotics reduces oxidative stress and improves the outcome of schizophrenia
  publication-title: Psychopharmacology
  doi: 10.1007/s00213-005-0117-1
  contributor:
    fullname: Dakhale
– volume: 69
  start-page: 429
  year: 2003
  ident: 10.1097/MAJ.0000000000000531_bb0250
  article-title: Membrane polyunsaturated fatty acids and CSF cytokines in patients with schizophrenia
  publication-title: Prostaglandins Leukot Essent Fatty Acids
  doi: 10.1016/j.plefa.2003.08.015
  contributor:
    fullname: Yao
– volume: 29
  start-page: 671
  year: 2003
  ident: 10.1097/MAJ.0000000000000531_bb0020
  article-title: The stress cascade and schizophrenia: etiology and onset
  publication-title: Schizophr Bull
  doi: 10.1093/oxfordjournals.schbul.a007038
  contributor:
    fullname: Corcoran
– volume: 16
  start-page: 885
  year: 2011
  ident: 10.1097/MAJ.0000000000000531_bb0260
  article-title: Progressive increase in striatal dopamine synthesis capacity as patients develop psychosis: a PET study
  publication-title: Mol Psychiatry
  doi: 10.1038/mp.2011.20
  contributor:
    fullname: Howes
– volume: 11
  start-page: 523
  year: 2009
  ident: 10.1097/MAJ.0000000000000531_bb0065
  article-title: Increased oxidative stress in the anterior cingulate cortex of subjects with bipolar disorder and schizophrenia
  publication-title: Bipolar Disord
  doi: 10.1111/j.1399-5618.2009.00717.x
  contributor:
    fullname: Wang
– volume: 49
  start-page: 243
  year: 2001
  ident: 10.1097/MAJ.0000000000000531_bb0275
  article-title: Two double-blind placebo-controlled pilot studies of eicosapentaenoic acid in the treatment of schizophrenia
  publication-title: Schizophr Res
  doi: 10.1016/S0920-9964(00)00083-9
  contributor:
    fullname: Peet
– volume: 30
  start-page: 193
  year: 1998
  ident: 10.1097/MAJ.0000000000000531_bb0055
  article-title: The membrane phospholipid hypothesis as a biochemical basis for the neurodevelopmental concept of schizophrenia
  publication-title: Schizophr Res
  doi: 10.1016/S0920-9964(97)00151-5
  contributor:
    fullname: Horrobin
– volume: 141
  start-page: 162
  year: 2012
  ident: 10.1097/MAJ.0000000000000531_bb0115
  article-title: Effects of omega-3 dietary supplement in prevention of positive, negative and cognitive symptoms: a study in adolescent rats with ketamine-induced model of schizophrenia
  publication-title: Schizophr Res
  doi: 10.1016/j.schres.2012.08.002
  contributor:
    fullname: Gama
– volume: 2013
  start-page: 686304
  year: 2013
  ident: 10.1097/MAJ.0000000000000531_bb0235
  article-title: Antipsychotic-like effect of trimetazidine in a rodent model
  publication-title: ScientificWorldJournal
  doi: 10.1155/2013/686304
  contributor:
    fullname: Erbas
– volume: 13
  start-page: 195
  year: 1994
  ident: 10.1097/MAJ.0000000000000531_bb0100
  article-title: The membrane hypothesis of schizophrenia
  publication-title: Schizophr Res
  doi: 10.1016/0920-9964(94)90043-4
  contributor:
    fullname: Horrobin
SSID ssj0012813
Score 2.1837142
Snippet Background In humans, omega-3 fatty acids are necessary for cell membranes, brain function and nerve transmission continuation. When animals are exposed to a...
In humans, omega-3 fatty acids are necessary for cell membranes, brain function and nerve transmission continuation. When animals are exposed to a new...
BACKGROUND:In humans, omega-3 fatty acids are necessary for cell membranes, brain function and nerve transmission continuation. When animals are exposed to a...
BACKGROUNDIn humans, omega-3 fatty acids are necessary for cell membranes, brain function and nerve transmission continuation. When animals are exposed to a...
SourceID proquest
crossref
pubmed
wolterskluwer
elsevier
SourceType Aggregation Database
Index Database
Publisher
StartPage 212
SubjectTerms Animals
Antipsychotic Agents - pharmacology
Antipsychotic effect
Apomorphine - pharmacology
Behavior, Animal - drug effects
Brain - drug effects
Brain - metabolism
Chlorpromazine - pharmacology
Docosahexaenoic Acids - pharmacology
Dopamine Agonists - pharmacology
Eicosapentaenoic Acid - pharmacology
Glutathione - metabolism
Internal Medicine
Lipid Peroxidation - drug effects
Male
Malondialdehyde - metabolism
Omega-3 fatty acids
Oxidative stress
Oxidative Stress - drug effects
Rats, Wistar
Stereotyped Behavior - drug effects
Title The Antipsychotic Effects of Omega-3 Fatty Acids in Rats
URI https://www.clinicalkey.es/playcontent/1-s2.0-S0002962915412698
https://dx.doi.org/10.1097/MAJ.0000000000000531
https://www.ncbi.nlm.nih.gov/pubmed/26200950
https://search.proquest.com/docview/1708898579
Volume 350
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3da9swEBdpB2NjjH0v-8KDvQVvlmRb9mNIU7KNbNCmMPYiJEfuTBY7zDaj__1Olhw7zbovWB5MkGVL1p3ufifdnRB6hU1WE-oSGUjXX1LfjcMAhKGggS9BxZFmQX92yj58io6m_nQwaI807Mr-K6WhDGitI2f_gtrbl0IB_AeawxWoDtc_pvs4rzIbXpUlo2nnsvFxrc6FS0fHogLwPU4y4w57Ikw-pxalLrpwk7yfW0KD1LXd2bGqs9sLKlYiuWig6Fx9WatqNBN5ljbOAvOtW_Gk2BTnX2tdeLbOKi2qKrME29U5Klb1RZ3UFtWqze7ttzm815wWptaid8-uXeBg65zVl8dxaNc8rDymJhOtZTy6I11JT1ETE_S5pwNMbuH5-J3JTdn-AqttdlJuTyfvsVuS1557qvuiuwKYEpPQHI19KRU35iXhHt-reoCuEZBzWsx-Dk62m1gkwrS1vnT1NnIzZm9-1rurkNG-5XMT3fpeaGeKctXEUvQQ0eIOum1NGWdsePAuGqj8Hro-t84a91EEbOTssKJjWdEpUseyotOwotOwopPljmbFB-jseLqYzFx7UIeb-IDv3ChWej_e81KWhhIAZIJ9yWjKgiVbMpyGngiXjKTMTwShgmlMi2UcSRwqpmRCH6LDvMjVY-QEqaShFDKKU-UnJJJgVqURdA4M4ZiGeIjcdpD4xuRj4a0fBQwqvzyoQ8TakeRtrDFoR1XayVPyq4jaf9JOKYMyOTDab9p82ZKMg7DWO3AiV0UNbTHtVRgFLB6iR4aW26_QJ0OAveMNEd4hLjcB0b9s8ck_f-VTdKObmM_QYfWtVs_RQbmsXzTM_ANBGsCF
link.rule.ids 315,782,786,27933,27934
linkProvider Elsevier
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+Antipsychotic+Effects+of+Omega-3+Fatty+Acids+in+Rats&rft.jtitle=The+American+journal+of+the+medical+sciences&rft.au=Kokacya%2C+Mehmet+Hanifi%2C+MD&rft.au=Copoglu%2C+Umit+Sertan%2C+MD&rft.au=Dokuyucu%2C+Recep%2C+MD&rft.au=Inanir%2C+Sema%2C+MD&rft.date=2015-09-01&rft.issn=0002-9629&rft.volume=350&rft.issue=3&rft.spage=212&rft.epage=217&rft_id=info:doi/10.1097%2FMAJ.0000000000000531&rft.externalDBID=ECK1-s2.0-S0002962915412698&rft.externalDocID=1_s2_0_S0002962915412698
thumbnail_m http://sdu.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F00029629%2FS0002962915X53006%2Fcov150h.gif